{
  "retracted": false,
  "timestamp": 1508112000000,
  "updates": [
    {
      "timestamp": 1585471802114,
      "identifier": {
        "doi": "10.1007/s00280-017-3448-9"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00280-017-3405-7"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma"
}
